720 related articles for article (PubMed ID: 27164932)
1. Comparative interactomics analysis of different ALS-associated proteins identifies converging molecular pathways.
Blokhuis AM; Koppers M; Groen EJN; van den Heuvel DMA; Dini Modigliani S; Anink JJ; Fumoto K; van Diggelen F; Snelting A; Sodaar P; Verheijen BM; Demmers JAA; Veldink JH; Aronica E; Bozzoni I; den Hertog J; van den Berg LH; Pasterkamp RJ
Acta Neuropathol; 2016 Aug; 132(2):175-196. PubMed ID: 27164932
[TBL] [Abstract][Full Text] [Related]
2. ALS-related FUS mutations alter axon growth in motoneurons and affect HuD/ELAVL4 and FMRP activity.
Garone MG; Birsa N; Rosito M; Salaris F; Mochi M; de Turris V; Nair RR; Cunningham TJ; Fisher EMC; Morlando M; Fratta P; Rosa A
Commun Biol; 2021 Sep; 4(1):1025. PubMed ID: 34471224
[TBL] [Abstract][Full Text] [Related]
3. TDP-43/FUS in motor neuron disease: Complexity and challenges.
Guerrero EN; Wang H; Mitra J; Hegde PM; Stowell SE; Liachko NF; Kraemer BC; Garruto RM; Rao KS; Hegde ML
Prog Neurobiol; 2016; 145-146():78-97. PubMed ID: 27693252
[TBL] [Abstract][Full Text] [Related]
4. The Fragile X Protein Family in Amyotrophic Lateral Sclerosis.
Mueller S; Decker L; Menge S; Ludolph AC; Freischmidt A
Mol Neurobiol; 2023 Jul; 60(7):3898-3910. PubMed ID: 36991279
[TBL] [Abstract][Full Text] [Related]
5. Targeting RACK1 to alleviate TDP-43 and FUS proteinopathy-mediated suppression of protein translation and neurodegeneration.
Zhao B; Cowan CM; Coutts JA; Christy DD; Saraph A; Hsueh SCC; Plotkin SS; Mackenzie IR; Kaplan JM; Cashman NR
Acta Neuropathol Commun; 2023 Dec; 11(1):200. PubMed ID: 38111057
[TBL] [Abstract][Full Text] [Related]
6. Mice Carrying ALS Mutant TDP-43, but Not Mutant FUS, Display In Vivo Defects in Axonal Transport of Signaling Endosomes.
Sleigh JN; Tosolini AP; Gordon D; Devoy A; Fratta P; Fisher EMC; Talbot K; Schiavo G
Cell Rep; 2020 Mar; 30(11):3655-3662.e2. PubMed ID: 32187538
[TBL] [Abstract][Full Text] [Related]
7. Humanized mutant FUS drives progressive motor neuron degeneration without aggregation in 'FUSDelta14' knockin mice.
Devoy A; Kalmar B; Stewart M; Park H; Burke B; Noy SJ; Redhead Y; Humphrey J; Lo K; Jaeger J; Mejia Maza A; Sivakumar P; Bertolin C; Soraru G; Plagnol V; Greensmith L; Acevedo Arozena A; Isaacs AM; Davies B; Fratta P; Fisher EMC
Brain; 2017 Nov; 140(11):2797-2805. PubMed ID: 29053787
[TBL] [Abstract][Full Text] [Related]
8. Mutations in FUS lead to synaptic dysregulation in ALS-iPSC derived neurons.
Shum C; Hedges EC; Allison J; Lee YB; Arias N; Cocks G; Chandran S; Ruepp MD; Shaw CE; Nishimura AL
Stem Cell Reports; 2024 Feb; 19(2):187-195. PubMed ID: 38242131
[TBL] [Abstract][Full Text] [Related]
9. Fly for ALS: Drosophila modeling on the route to amyotrophic lateral sclerosis modifiers.
Liguori F; Amadio S; Volonté C
Cell Mol Life Sci; 2021 Sep; 78(17-18):6143-6160. PubMed ID: 34322715
[TBL] [Abstract][Full Text] [Related]
10. U1 snRNP is mislocalized in ALS patient fibroblasts bearing NLS mutations in FUS and is required for motor neuron outgrowth in zebrafish.
Yu Y; Chi B; Xia W; Gangopadhyay J; Yamazaki T; Winkelbauer-Hurt ME; Yin S; Eliasse Y; Adams E; Shaw CE; Reed R
Nucleic Acids Res; 2015 Mar; 43(6):3208-18. PubMed ID: 25735748
[TBL] [Abstract][Full Text] [Related]
11. PP2A and GSK3 act as modifiers of FUS-ALS by modulating mitochondrial transport.
Tziortzouda P; Steyaert J; Scheveneels W; Sicart A; Stoklund Dittlau K; Barbosa Correia AM; Burg T; Pal A; Hermann A; Van Damme P; Moens TG; Van Den Bosch L
Acta Neuropathol; 2024 Feb; 147(1):41. PubMed ID: 38363426
[TBL] [Abstract][Full Text] [Related]
12. Neuronal dysfunction caused by FUSR521G promotes ALS-associated phenotypes that are attenuated by NF-κB inhibition.
Pelaez MC; Desmeules A; Gelon PA; Glasson B; Marcadet L; Rodgers A; Phaneuf D; Pozzi S; Dutchak PA; Julien JP; Sephton CF
Acta Neuropathol Commun; 2023 Nov; 11(1):182. PubMed ID: 37974279
[TBL] [Abstract][Full Text] [Related]
13. Mutant FUS and ELAVL4 (HuD) Aberrant Crosstalk in Amyotrophic Lateral Sclerosis.
De Santis R; Alfano V; de Turris V; Colantoni A; Santini L; Garone MG; Antonacci G; Peruzzi G; Sudria-Lopez E; Wyler E; Anink JJ; Aronica E; Landthaler M; Pasterkamp RJ; Bozzoni I; Rosa A
Cell Rep; 2019 Jun; 27(13):3818-3831.e5. PubMed ID: 31242416
[TBL] [Abstract][Full Text] [Related]
14. FUS-SMN protein interactions link the motor neuron diseases ALS and SMA.
Yamazaki T; Chen S; Yu Y; Yan B; Haertlein TC; Carrasco MA; Tapia JC; Zhai B; Das R; Lalancette-Hebert M; Sharma A; Chandran S; Sullivan G; Nishimura AL; Shaw CE; Gygi SP; Shneider NA; Maniatis T; Reed R
Cell Rep; 2012 Oct; 2(4):799-806. PubMed ID: 23022481
[TBL] [Abstract][Full Text] [Related]
15. Fused in sarcoma (FUS) protein lacking nuclear localization signal (NLS) and major RNA binding motifs triggers proteinopathy and severe motor phenotype in transgenic mice.
Shelkovnikova TA; Peters OM; Deykin AV; Connor-Robson N; Robinson H; Ustyugov AA; Bachurin SO; Ermolkevich TG; Goldman IL; Sadchikova ER; Kovrazhkina EA; Skvortsova VI; Ling SC; Da Cruz S; Parone PA; Buchman VL; Ninkina NN
J Biol Chem; 2013 Aug; 288(35):25266-25274. PubMed ID: 23867462
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of β-catenin due to loss of miR-139 contributes to motor neuron death in amyotrophic lateral sclerosis.
Hawkins S; Namboori SC; Tariq A; Blaker C; Flaxman C; Dey NS; Henley P; Randall A; Rosa A; Stanton LW; Bhinge A
Stem Cell Reports; 2022 Jul; 17(7):1650-1665. PubMed ID: 35750046
[TBL] [Abstract][Full Text] [Related]
17. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6.
Vance C; Rogelj B; Hortobágyi T; De Vos KJ; Nishimura AL; Sreedharan J; Hu X; Smith B; Ruddy D; Wright P; Ganesalingam J; Williams KL; Tripathi V; Al-Saraj S; Al-Chalabi A; Leigh PN; Blair IP; Nicholson G; de Belleroche J; Gallo JM; Miller CC; Shaw CE
Science; 2009 Feb; 323(5918):1208-1211. PubMed ID: 19251628
[TBL] [Abstract][Full Text] [Related]
18. Zebrafish CCNF and FUS Mediate Stress-Specific Motor Responses.
Aksoy YA; Cole AJ; Deng W; Hesselson D
Cells; 2024 Feb; 13(5):. PubMed ID: 38474336
[TBL] [Abstract][Full Text] [Related]
19. Molecular determinants and genetic modifiers of aggregation and toxicity for the ALS disease protein FUS/TLS.
Sun Z; Diaz Z; Fang X; Hart MP; Chesi A; Shorter J; Gitler AD
PLoS Biol; 2011 Apr; 9(4):e1000614. PubMed ID: 21541367
[TBL] [Abstract][Full Text] [Related]
20. Animal Models of FUS-Proteinopathy: A Systematic Review.
Rezvykh A; Shteinberg D; Bronovitsky E; Ustyugov A; Funikov S
Biochemistry (Mosc); 2024 Jan; 89(Suppl 1):S34-S56. PubMed ID: 38621743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
